Fundraising Fox
H+Trace
Techstars '24Allen, US · Founded 2021 · 6 employees on LinkedIn · 4 known investors
Find your way into H+Trace
Sign up to see every warm intro you have to H+Trace
- Paths you didn't know you had: your email and LinkedIn already hold routes to the H+Trace team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
H-Trace provides artificial intelligence-powered traceability monitoring for healthcare supply chains, using proprietary contactless sensor technology to predict and prevent shipment failures without requiring manual intervention or package opening. The platform serves clinical laboratories, pharmaceuticals, clinical research organizations, and logistics providers.
Also known as H-Trace · H+Trace · HTrace
Founders & leadership
H+Trace was founded in 2021 by Javier Cuello.
Investors · 4
How we know: the Techstars portfolio · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · research · refreshmiami.com · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Also in the syndicate · 2
Company profile
researched Sep 2026H+Trace is a healthcare supply chain traceability company whose platform monitors and verifies shipments of biological samples and other medical goods from collection through analysis. Its proprietary Contactless MultiSense (CMS) technology is a combined hardware and software system that generates and processes logistics data without opening the packaging, recording vial temperature and detecting whether items have been tampered with, shaken or mishandled. Data is transmitted from the devices to the cloud via the company's mobile app, giving users real-time information, and the company applies artificial intelligence to historical shipment data with the aim of forecasting failures before they occur rather than only tracking shipments after the fact.
The company positions the platform as fully automated, wireless and zero-touch, requiring no human input or added steps in the collection workflow. It states that customer data is stored on servers located in the United States, kept private to each client, and can optionally be decentralized using blockchain. The company describes its purpose as ensuring medical decisions reflect accurate information and its stated vision is to become a global leader in smart monitoring.
H+Trace's product line includes four AI-powered devices that monitor temperature and detect tampering. Among them is the PACK Smart Device, which the company describes as the only device on the market offering passive contact-based cooling and freezing so that samples are conditioned from the moment of collection. Device components are sourced from other countries and assembled in Hialeah, Florida.
Founding story
The concept arose after a friend of Javier Cuello was mistakenly diagnosed with gestational diabetes while pregnant with twins, having received another woman's test results and been told to lose weight, which put her pregnancy at risk. Cuello investigated the healthcare supply chain and the laboratory space and found that two out of three laboratory errors occur before a sample is analyzed, in the interval between blood draw and the analyzer, and that no device or technology on the market supplied the data needed to improve that process. He assembled the team that became H+Trace. Before this, Cuello was an early user of fiberoptics to record live concerts in Latin America, working with the Rolling Stones, AC/DC and Madonna, sold that company in 2016, and served as head of science, technology and innovation for the City of Buenos Aires. Co-founder Ivan Fardjoume is also a serial entrepreneur.
Business model
H+Trace sells a combined hardware-and-software monitoring service to laboratories, pharmaceutical firms, CROs and logistics providers. Customers can choose a flat rate with no monthly trip limit or pay per trip, and devices can either be purchased outright or supplied on loan. The service includes unlimited licenses and users with no restrictions and no additional or hidden fees, and a free seven-day trial (shipping costs excluded) is offered. Implementation is designed to take under 24 hours, requiring only the download of the mobile app and pairing of a device, with no prior training.
Revenue comes from subscription or usage-based service contracts, offered either as a flat rate with no monthly trip limit or on a per-trip basis, plus device sales; devices may alternatively be loaned to customers. Licenses and user seats are unlimited within the service fee.
Traction
Over an 18-month period the company collected and delivered more than 11 million samples across Argentina, Mexico and the Dominican Republic. It operated with a team of seven at the time of its pre-seed raise, with plans to expand to 20.
Latest developments
H+Trace raised $500,000 in pre-seed funding from backers including Techstars, two Argentine family offices and a general partner at NXTP Ventures, intended mainly for growth alongside continued development of a machine-learning algorithm for error prediction and further device development. The founders planned to grow the team from seven to 20 people, establish U.S. headquarters in downtown Miami, and begin U.S. operations with at-home blood collections in retirement homes.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
The company targets a stage of the diagnostic process that it says is often overlooked: the period between blood draw and analysis, where it states two of every three laboratory errors occur. Techstars Managing Director Andres Barreto described the company as focusing on what happens before analysis, a space many overlook.
The company frames its offering as predictive rather than purely descriptive tracking, applying machine learning to a customer's own historical shipment data to anticipate failures. Its Contactless MultiSense technology captures data without opening packaging, and the founders state they built each smart device themselves after finding no existing market technology capable of supplying the data they required. The company describes its PACK Smart Device as the only device on the market with passive contact-based cooling and freezing.
Technology
The core technology is Contactless MultiSense (CMS), a proprietary hardware and software platform that tracks and verifies samples from collection through analysis without opening packaging. The smart devices record vial temperature and detect tampering, shaking or mishandling, and transmit data to the cloud through the company's mobile app for real-time visibility. The company was developing a machine-learning algorithm to predict errors from a customer's past shipment data. Four AI-powered devices monitor temperature and detect tampering; the PACK Smart Device provides passive contact-based cooling and freezing at the point of collection. Data is held on U.S. servers, segregated per client, with optional blockchain-based decentralization.
Go-to-market
The company sells directly to laboratories and healthcare logistics operators, emphasizing rapid onboarding, a free seven-day trial and flexible device acquisition terms. In the United States it planned to begin with at-home blood collections in retirement homes and retirement communities in the Miami area before expanding to hospitals and clinical labs nationally. It has used accelerator and ecosystem programs, including the 2025 spring EndeavorLAB cohort of Endeavor Miami, and cites Miami's ability to attract talent from the U.S., Latin America and Europe and to serve both regions.
Clinical laboratories, pharmaceutical companies, Clinical Research Organizations and supply chain and logistics companies; in the United States, initially retirement homes and communities for at-home blood collection, then hospitals and clinical labs.
Geography
Operations span Latin America and the United States. The company has collected and delivered samples across Argentina, Mexico and the Dominican Republic, with Brazil and the United States identified as next markets. The technology team is based in Argentina, a directory listing gives a Buenos Aires main office, devices are assembled in Hialeah, Florida, and the website lists a Miami address at 2125 Biscayne Blvd; the founders plan to make downtown Miami the headquarters for U.S. operations. Servers holding customer data are located in the United States.
History
The company was founded in 2021 by Argentinian entrepreneurs Javier Cuello and Ivan Fardjoume, who met in 2018 during a Motorola competition where Cuello was a judge and Fardjoume was head of technology for the contest. Because no existing device provided the data the founders needed, they built each smart device from scratch. Over an 18-month period the company collected and delivered more than 11 million samples in Argentina, Mexico and the Dominican Republic, with Brazil and the United States planned next. Fardjoume leads the technology team in Argentina, while Cuello has driven the move into the U.S. market, including participation in the 2025 spring EndeavorLAB cohort of Endeavor Miami and a $500,000 pre-seed raise used primarily for growth.
Compiled by commissioned research from 7 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 3
launches, deals, and filingsThe co-founders plan to establish downtown Miami as the headquarters for U.S. operations and to bring the technology to hospitals and clinical labs across the country, starting with at-home blood collections in retirement homes.
H+Trace raised $500,000 in pre-seed funding to support expansion and continued product development, with backers including Techstars, two Argentine family offices and a general partner at NXTP Ventures.
$500K source ↗
Co-founder Javier Cuello participated in the 2025 spring EndeavorLAB accelerator cohort, part of Endeavor Miami.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 7
primary sources listed
- H+Traceh-trace.com · web
7 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does H+Trace do?
- H+Trace uses AI and contactless sensor devices to monitor and predict failures in healthcare supply chains and lab sample transport.
- Who founded H+Trace?
- H+Trace was founded by Javier Cuello in 2021.
- Who are H+Trace's investors?
- H+Trace's investors include Techstars, Firstrock Capital.
- Where is H+Trace headquartered?
- H+Trace is headquartered in Allen, US.